Equivocal (HER2 IHC 2+) breast carcinomas: gene-protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefits
Pekar, Gyula, Kasselaki, Ioanna, Lukacs, Agnes P., Dekany, Csaba, Hellberg, Dan, Tot, TiborLanguage:
english
Journal:
Histopathology
DOI:
10.1111/his.13733
Date:
August, 2018
File:
PDF, 1.93 MB
english, 2018